-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Organogenesis Holdings, Lowers Price Target to $2

Benzinga·08/07/2026 13:24:19
Listen to the news
Truist Securities analyst Ravi Misra maintains Organogenesis Holdings (NASDAQ:ORGO) with a Hold and lowers the price target from $3 to $2.